Skip to navigation menu Skip to content
Clinical Trial Search block Test

Multicenter, Open-label, Phase 2, Extension Trial to Study the Long-Term Safety in Participants With PROS or Proteus Syndrome Who Are Currently Being Treated with Miransertib in Other Studies

ARQ_Extension

What is the goal of the study?

To learn more about this study, please email the study team member listed below.

Who can participate in the study?

Everyone

Study Team: